Chemical Structure : GSK1904529A
CAS No.: 1089283-49-7
Catalog No.: PC-42636Not For Human Use, Lab Use Only.
GSK1904529A is a potent, selective, ATP-competitive inhibitor of IGF-1R and IR with IC50 of 27 nM and 25 nM.
| Packing | Price | Stock | Quantity | 
|---|---|---|---|
| 5 mg | $78 | In stock | |
| 10 mg | $118 | In stock | |
| 25 mg | $198 | In stock | |
| 50 mg | Get quote | ||
| 100 mg | Get quote | 
Bulk size, bulk discount!
Welcome credit card payment!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
	GSK1904529A is a potent, selective, ATP-competitive inhibitor of IGF-1R and IR with IC50 of 27 nM and 25 nM.
	GSK1904529A showes poor activity in a panel of 45 other serine/threonine and tyrosine kinases.
	GSK1904529A potently inhibits phosphorylation of IGF-IR (IC50=22 nM) and IR (IC50=19 nM).
	GSK1904529A decreases the growth of human tumor xenografts in mice; orally active.
| M.Wt | 851.9631 | |
| Formula | C44H47F2N9O5S | |
| Appearance | Solid | |
| Storage | 
                            
  | 
                        
                            
  | 
                    
| Solubility | 
                             10 mM in DMSO  | 
                    |
| Chemical Name/SMILES | 
                             Benzamide, N-(2,6-difluorophenyl)-5-[3-[2-[[5-ethyl-2-methoxy-4-[4-[4-(methylsulfonyl)-1-piperazinyl]-1-piperidinyl]phenyl]amino]-4-pyrimidinyl]imidazo[1,2-a]pyridin-2-yl]-2-methoxy-  | 
                    |
1. Sabbatini P, et al. Clin Cancer Res. 2009 May 1;15(9):3058-67.
2. Zhou Q, et al. Mol Med Rep. 2015 Sep;12(3):3381-5.
3. Fei HD, et al. Oncotarget. 2017 May 16.

                
                
                
                
                
                
                
                
            
            
        Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright